Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.230
+0.120 (3.86%)
At close: Jun 18, 2026, 4:00 PM EDT
3.180
-0.050 (-1.55%)
After-hours: Jun 18, 2026, 7:57 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.71 billion as of June 18, 2026. Its market cap has decreased by -14.19% in one year.
Market Cap
1.71B
Enterprise Value
1.13B
1-Year Change
-14.19%
Ranking
Category
Stock Price
$3.23
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.71B, a decrease of -66.22%. That is a compound annual growth rate of -18.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.71B | -19.46% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.69B |
| Syndax Pharmaceuticals | 1.69B |
| Precigen | 1.69B |
| Innoviva | 1.67B |
| AbCellera Biologics | 1.66B |
| Sionna Therapeutics | 1.66B |
| AnaptysBio | 1.65B |
| Capricor Therapeutics | 1.62B |